Powered by: Motilal Oswal
2024-09-09 10:07:54 am | Source: Accord Fintech
Krishna Institute rises as its arm enters into lease agreement with Sree Chand Specialty Hospitals

Krishna Institute of Medical Sciences is currently trading at Rs. 2685.00, up by 29.05 points or 1.09% from its previous closing of Rs. 2655.95 on the BSE.

The scrip opened at Rs. 2692.95 and has touched a high and low of Rs. 2692.95 and Rs. 2655.00 respectively. So far 522 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 2,692.95 on 09-Sep-2024 and a 52 week low of Rs. 1625.05 on 16-Oct-2023.

Last one week high and low of the scrip stood at Rs. 2692.95 and Rs. 2519.70 respectively. The current market cap of the company is Rs. 21254.98 crore.

The promoters holding in the company stood at 38.82%, while Institutions and Non-Institutions held 49.96% and 11.22% respectively.

Krishna Institute of Medical Sciences through its wholly owned subsidiary i.e. KIMS Swastha has entered into a long-term lease and operations and management agreement with Sree Chand Specialty Hospital, situated in Kannur. 

Established in 2020, Sree Chand Specialty Hospital currently operates with 189 beds, six operating theatres, and one cath lab. Under the new agreement, the hospital will be rebranded as KIMS Sreechand Specialty Hospital and undergo a major transformation. The facility will be expanded to a 350-bed quaternary care unit, offering state-of-the-art facilities across all departments with a particular emphasis on advanced Transplants, Robotic Surgeries, and Comprehensive Cancer Care.

Krishna Institute of Medical Sciences offers a comprehensive range of healthcare services including oncology, cardiac sciences, neurosciences, gastric sciences, orthopaedics, renal sciences, organ transplantation, and mother & child care.

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here